Q4 2016 13F Holders as of 12/31/2016
-
Type / Class
-
Equity / Common Stock, No Par Value Per Share
-
Shares outstanding
-
50.4M
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
9.45M
-
Shares change
-
+1.68M
-
Total reported value, excl. options
-
$28.3M
-
Value change
-
+$5.29M
-
Put/Call ratio
-
0.81
-
Number of buys
-
22
-
Number of sells
-
-16
-
Price
-
$3.00
Significant Holders of Vericel Corp - Common Stock, No Par Value Per Share (VCEL) as of Q4 2016
51 filings reported holding VCEL - Vericel Corp - Common Stock, No Par Value Per Share as of Q4 2016.
Vericel Corp - Common Stock, No Par Value Per Share (VCEL) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 9.45M shares
of 50.4M outstanding shares and own 18.74% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (2.98M shares), Stonepine Capital Management, LLC (1.88M shares), BlackRock Institutional Trust Company, N.A. (1.05M shares), VANGUARD GROUP INC (726K shares), Alyeska Investment Group, L.P. (688K shares), RENAISSANCE TECHNOLOGIES LLC (437K shares), DSC Advisors, L.P. (364K shares), PERKINS CAPITAL MANAGEMENT INC (229K shares), SABBY MANAGEMENT, LLC (150K shares), and DEUTSCHE BANK AG\ (135K shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.